Observational study shows higher atherogenic index of plasma correlates with increased MACE risk in people with metabolic syndrome, suggesting its role in risk stratification.
This observational study showed that higher AIP was associated with increased risks of MACE and its component endpoints, highlighting its potential as a biomarker for risk stratification among individuals with MetS.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: